Phase I Study of Medical Food for the Dietary Management of Metastatic Pancreatic Cancer (NEAAR)
The purpose of this study is to evaluate the tolerability and markers of pancreatic cancer with a specially designed medical food restricted in specific amino acids for the dietary management of patients with metastatic pancreatic adenocarcinoma.
Study ID: NEAAR-001
Trial Phase: Phase I
Trial Sponsor: Faeth Therapeutics
Therapies Used in This Trial: Nab-paclitaxel, Gemcitabine, (NEAAR) Medical Food